Dabigatran (Pradaxa) is a new oral anticoagulant that has recently been licensed for use in atrial fibrillation to prevent strokes. Dabigatran is at least as effective as warfarin in reducing strokes in patients with atrial fibrillation. An important advantage to warfarin is that dabigatran does not require regular blood tests like warfarin to stabilise the dose. This is a welcome development, particularly for patients that have problems with regular blood tests and those that have erratic INR readings. Dabigatran is now available in the UK if it is prescribed by a doctor.
- Dr Howard MarshallHoward Marshall trained at Leeds University graduating in 1988. After moving to the Midlands for specialist training he gained his MD from the University of Birmingham focusing on Atrioventricular Node Ablation and Pacing in the Treatment of Atrial Fibrillation. » Read More
This is a general term that describes some of the procedures that we perform. Ablation is the process that modifies small parts of the heart muscle that are responsible for the abnormal heart rhythms or palpitations. Usually this is done by heating the area using radiofrequency at the end of a catheter that is placed in contact with the heart muscle.